All Pharma articles – Page 42
-
Comment
Mark Goldman on a happy ending for NHS top-ups
Are you sitting comfortably? Then I will begin. Once upon a time there was an elusive apostrophe. He lived in the NHS and was always causing mischief with his friend 'patients'. Together they would hide from the managers and clinicians.
-
News
Britain 'faces pharmaceutical industry skills gap'
A report by the Association of the British Pharmaceutical Industry says a lack of skills will threaten the long-term future of biomedicine in the country.
-
HSJ Knowledge
Supporting NICE in assessing delivery on advice
The NHS Information Centre's prescribing support unit produces data that allows the National Institute for Health and Clinical Excellence to review current patterns of care; to estimate the potential cost of recommendations; and to monitor the implementation of their guidance.
-
News
Scotland next to review NHS top-ups
Scottish health secretary Nicola Sturgeon has today pledged to review Scottish policy on topping up NHS care with private payments.
-
News
Welsh group to report on NHS funding for non-approved drugs
An expert group set up by the Welsh health minister to look at funding drugs on the NHS that have not been approved by the National Institute for Health and Clinical Excellence is to report in the new year, it has been announced.
-
News
Partnership plan for top-ups
Advances in medical technology and drug treatments mean it is more important than ever that the health service and private sector work together to create a system which works in the best interests of all patients.
-
News
Young children should not be given Ritalin - NICE
Ritalin should not be routinely prescribed for children and should never be given to those under five, the National Institute for Health and Clinical Excellence has advised.
-
News
Prescription drug marketing comes under debate
Organisations representing patients, medical professionals and consumers are calling on the European Commission to rethink proposals to allow drug companies to provide information direct to consumers.
-
News
Andrew Lansley backs value-based drug pricing
Pharmaceutical companies should be paid according to the benefits that their drugs bring to patients, shadow health secretary Andrew Lansley has said.
-
News
Scottish walk-in pharmacy services launched
Eight Scottish pharmacies are piloting walk-in services such as immunisation, health checks, nurse-led minor injury clinics, sexual healthcare and smoking cessation. The pharmacies will stay open until midnight six days a week during the pilot, which is due to run until March 2010.
-
News
Top-ups should be allowed, says King's Fund chief
The NHS should not deny treatment to patients who pay privately for unapproved drugs, King's Fund chief executive Niall Dickson has said.He told a seminar yesterday: 'The current practice on top-ups, which prohibits people from privately purchasing drugs not available on the health service while continuing a course of NHS ...
-
News
High Court decision on cancer drug
The High Court has overturned a primary care trust's refusal to fund cancer drug Revlimid for a cancer suffer with only months to live.
-
News
Liberal Democrats voice support for top ups
Liberal Democrat leader Nick Clegg has called for patients to be allowed to pay for extra treatment without losing the right to free NHS care.
-
News
Pharmacists 'could reduce GP workloads by 20 per cent'
Pharmacists could reduce GP workloads by 20 per cent, the president of the Royal Pharmaceutical Society of Great Britain has told the British Pharmaceutical Conference.
-
News
Top-ups: experts divided over health's thorniest issue
Should patients be allowed to top up their care by paying privately for drugs? The question has confounded experts and now the government has an unenviable task in making a final decision. Helen Crump reports
-
News
NICE guidance could revolutionise diabetes care
New guidance from the National Institute for Health and Clinical Excellence looks set to revolutionise the way children manage their diabetes by offering greater access to insulin pump therapy, says drugs firm Roche.
-
News
Anti-psychosis drugs may increase risk of stroke, study finds
All drugs used to treat psychosis are linked to an increased risk of stroke, and dementia sufferers are at double the risk, a study published on www.bmj.com has shown.
-
HSJ Knowledge
NICE awards promote shared learning
With the next stage review promoting quality over cost, now is the time to develop better ways of sharing best practice. As the closing date for the annual NICE awards nears, HSJ talks to last year's winners
-
News
Drug treatment link to benefits is concerning
Bravo, Paul Hayes, for declaring the direct interest of the National Treatment Agency in the green paper on welfare 'reform'.
-
News
NICE gives go-ahead for Lucentis
The National Institute for Health and Clinical Excellence has said primary care trusts should fund the use of ranibizumab - commonly known as Lucentis - for the treatment of wet age-related macular degeneration if certain conditions apply.